Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venous Thrombosis or Pulmonary Embolism”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Large-scale testing (Phase 3)UnknownNCT00222677
What this trial is testing

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism+1 more
University Of Perugia 70
Testing effectiveness (Phase 2)Study completedNCT00306254
What this trial is testing

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Who this might be right for
Venous Thrombosis
Pfizer 1,225
Not applicableLooking for participantsNCT07288632
What this trial is testing

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Who this might be right for
Venous Thromboembolism (VTE)NSCLC (Advanced Non-small Cell Lung Cancer)
University Of Perugia 500
Not applicableUnknownNCT01717495
What this trial is testing

Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator Procedures

Who this might be right for
BradyarrhythmiasArrhythmiasCardiovascular Disease+2 more
University of Sao Paulo 1
Large-scale testing (Phase 3)Study completedNCT00633893
What this trial is testing

Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Who this might be right for
Venous Thrombosis
Bristol-Myers Squibb 2,711
Not applicableLooking for participantsNCT07350499
What this trial is testing

Aspiration Thrombectomy Using the Symphony or Prodigy System

Who this might be right for
Arterial ThromboembolismVenous ThromboembolismPulmonary Embolism
Imperative Care, Inc. 750
Post-approval studies (Phase 4)Active Not RecruitingNCT07250763
What this trial is testing

Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital

Who this might be right for
Pulmonary EmbolismDeep Vein ThrombosisAtrial Fibrillation+2 more
Inova Health Care Services 145
Large-scale testing (Phase 3)Study completedNCT04646655
What this trial is testing

Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19

Who this might be right for
Covid19Thrombosis
ASST Fatebenefratelli Sacco 142
Large-scale testing (Phase 3)Study completedNCT00439777
What this trial is testing

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study

Who this might be right for
Pulmonary Embolism
Bayer 4,833
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Post-approval studies (Phase 4)Study completedNCT00365950
What this trial is testing

3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismDeep Vein Thrombosis With Pulmonary Embolism
British Thoracic Society 2,400
Large-scale testing (Phase 3)Study completedNCT02585713
What this trial is testing

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisGonadal Thrombosis+9 more
Academic and Community Cancer Research United 300
Not applicableStudy completedNCT00480636
What this trial is testing

Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

Who this might be right for
Acute Deep Vein Thrombosis
Pfizer 102
Large-scale testing (Phase 3)WithdrawnNCT01164540
What this trial is testing

Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis

Who this might be right for
Venous ThrombosisPulmonary Embolism
AstraZeneca 3,000
Not applicableStudy completedNCT02884934
What this trial is testing

Six Years of Follow-up After Idiopathic Venous Throbmoembolism

Who this might be right for
Pulmonary EmbolismProximal Deep Vein Thrombosis
University Hospital, Brest 409
Not applicableUnknownNCT00970892
What this trial is testing

VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management

Who this might be right for
Atrial FibrillationCardiac ThrombusDeep Vein Thrombosis+4 more
Ankara University 500
Not applicableStudy completedNCT02921802
What this trial is testing

Special Use Results Surveillance of Revlimid 5mg Capsules

Who this might be right for
Multiple MyelomaMyelodysplastic Syndromes
Celgene 4,626
Large-scale testing (Phase 3)Study completedNCT00439725
What this trial is testing

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Who this might be right for
Venous Thromboembolism
Bayer 1,197
Not applicableStudy completedNCT02922543
What this trial is testing

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Who this might be right for
Multiple Myeloma
Celgene 361
Large-scale testing (Phase 3)Study completedNCT00071279
What this trial is testing

SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis

Who this might be right for
Pulmonary EmbolismDeep Vein Thrombosis
Sanofi 1,215
Next Page